Local drug delivery strategy for cancer treatment: use of biocompatible sol-gel-derived porous materials

Porous silica xerogel materials have been developed to use as drug-release agents to be implanted directly in or near cancerous tissues. In order to test the capacity of the materials to absorb and then to release medicinal substances, a bat-tery of examinations (UV and visible micro-Raman, porosity measurements, UV-visible absorption spectra) have been made using test drug molecules (clotrimazole, primaquine diphosphate and the anti-cancer agent vinblastine sulphate). Results show that the molecules can be post-doped into the gels and the Raman data provide indications of the best conditions for detecting the substances absorbed in the gels. Spectroscopic results show that the drug molecules are re-leased by the xerogel over a period of 10 days. These results are promising for the development of these materials as drug-release agents.

Data and Resources

Additional Info

Field Value
Source New Journal of Glass and Ceramics
Author Cristini-Robbe, O., Ruyffelaere, F., Dubart, F., Uwimanimpaye, A., Kinowski, C., Bernard, R., Robbe-Masselot, C., El Yazidi, I., Turrell, S.
Maintainer CCSD
Last Updated May 10, 2026, 21:47 (UTC)
Created May 10, 2026, 21:47 (UTC)
Identifier hal-00829341
Language en
contributor Laboratoire de Physique des Lasers, Atomes et Molécules - UMR 8523 (PhLAM) ; Université de Lille-Centre National de la Recherche Scientifique (CNRS)
creator Cristini-Robbe, O.
date 2013-05-10T00:00:00
harvest_object_id e775dcb1-d189-4491-b2a5-d15aa38fd12b
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2025-11-20T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.4236/njgc.2013.32012
set_spec type:ART